skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Mitochondrial fragmentation in neuronal degeneration: Toward an understanding of HD striatal susceptibility

Journal Article · · Biochemical and Biophysical Research Communications
 [1];  [1]
  1. Departament de Biomedicina, Facultat de Medicina, Universitat de Barcelona, Barcelona (Spain)

Huntington's disease (HD) is an autosomal-dominant progressive neurodegenerative disorder that primarily affects medium spiny neurons within the striatum. HD is caused by inheritance of an expanded CAG repeat in the HTT gene, resulting in a mutant huntingtin (mHtt) protein containing extra glutamine residues. Despite the advances in understanding the molecular mechanisms involved in HD the preferential vulnerability of the striatum remains an intriguing question. This review discusses current knowledge that links altered mitochondrial dynamics with striatal susceptibility in HD. We also highlight how the modulation of mitochondrial function may constitute an attractive therapeutic approach to reduce mHtt-induced toxicity and therefore prevent the selective striatal neurodegeneration. - Highlights: • Mitochondrial dynamics is unbalanced towards fission in HD. • Excessive mitochondrial fragmentation plays a critical role in the selective vulnerability of the striatum in HD. • Therapeutic approaches aimed to inhibit mitochondrial fission could contribute to prevent striatal neurodegeneration in HD.

OSTI ID:
22696862
Journal Information:
Biochemical and Biophysical Research Communications, Vol. 483, Issue 4; Other Information: Copyright (c) 2016 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.; Country of input: International Atomic Energy Agency (IAEA); ISSN 0006-291X
Country of Publication:
United States
Language:
English

Similar Records

Inhibition of Drp1 hyperactivation reduces neuropathology and behavioral deficits in zQ175 knock-in mouse model of Huntington's disease
Journal Article · Sat Dec 15 00:00:00 EST 2018 · Biochemical and Biophysical Research Communications · OSTI ID:22696862

AAV-mediated delivery of the transcription factor XBP1s into the striatum reduces mutant Huntingtin aggregation in a mouse model of Huntington's disease
Journal Article · Fri Apr 13 00:00:00 EDT 2012 · Biochemical and Biophysical Research Communications · OSTI ID:22696862

CRISPR-Cas9-Mediated Genome Editing Increases Lifespan and Improves Motor Deficits in a Huntington’s Disease Mouse Model
Journal Article · Fri Sep 06 00:00:00 EDT 2019 · Molecular Therapy - Nucleic Acids · OSTI ID:22696862